NERVIGESIC M 75 CAP is a combination therapy capsule designed for comprehensive treatment of neuropathic pain and related neurological conditions. This advanced formula integrates Pregabalin 75 mg, a gamma-aminobutyric acid (GABA) analog, with Methylcobalamin, the active and bioavailable form of Vitamin B12, to deliver synergistic pain relief, nerve protection, and regeneration.

Pregabalin, the primary component, is well-known for its efficacy in chronic nerve pain conditions such as diabetic neuropathy, postherpetic neuralgia, fibromyalgia, and spinal cord injury-induced neuropathy. It works by modulating calcium channel activity in hyperexcited neurons, reducing the excessive release of excitatory neurotransmitters. This mechanism decreases hyperalgesia and allodynia, symptoms commonly associated with damaged or overactive nerves.

Methylcobalamin plays a key role in nerve repair and regeneration, helping restore the myelin sheath and improve axonal transport. It is essential for DNA synthesis and neurological function, and its deficiency often exacerbates symptoms of peripheral neuropathy. By combining Methylcobalamin with Pregabalin, NERVIGESIC M 75 CAP not only addresses the immediate symptoms of nerve pain but also supports long-term nerve health and functionality.

This formulation is widely prescribed in conditions where nerve pain coexists with nutritional nerve degeneration. It is highly effective for patients with diabetic peripheral neuropathy, vitamin B12 deficiency-induced neuralgia, and alcoholic neuropathy. Additionally, it is often used in orthopedic and post-surgical care to control nerve-related inflammation and pain.

NERVIGESIC M 75 CAP is manufactured by Bluepill Express under strict quality standards compliant with WHO-GMP and ISO certifications. The capsule is formulated for optimal gastrointestinal absorption and extended systemic availability, ensuring patients receive consistent therapeutic benefits with minimal fluctuations in blood levels. Each unit is packed in moisture-resistant, tamper-proof packaging to preserve stability throughout its shelf life.

Clinically, patients using NERVIGESIC M 75 CAP report improved pain control, reduced tingling and numbness, and better sleep patterns, particularly in cases of chronic or treatment-resistant nerve pain. Its balanced combination makes it suitable for long-term use under physician supervision. As a once or twice daily oral therapy, it ensures convenience and compliance, essential for patients managing ongoing neuropathic disorders.